Global Opioids Market Overview:
Global Opioids Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Opioids Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Opioids involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Opioids Market:
The Opioids Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Opioids Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Opioids Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Opioids market has been segmented into:
Codeine
Fentanyl
Morphine
Meperidine
Methadone
and Other Product Types
By Application, Opioids market has been segmented into:
Strong Agonist and Mild to Moderate Agonist
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Opioids market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Opioids market.
Top Key Players Covered in Opioids market are:
Mallinckrodt Pharmaceuticals
Amneal Pharmaceuticals Inc.
Hikma Pharmaceuticals PLC
Purdue Pharmaceuticals L.P.
Teva Pharmaceuticals Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Opioids Market Type
4.1 Opioids Market Snapshot and Growth Engine
4.2 Opioids Market Overview
4.3 Codeine
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Codeine: Geographic Segmentation Analysis
4.4 Fentanyl
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Fentanyl: Geographic Segmentation Analysis
4.5 Morphine
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Morphine: Geographic Segmentation Analysis
4.6 Meperidine
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Meperidine: Geographic Segmentation Analysis
4.7 Methadone
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Methadone: Geographic Segmentation Analysis
4.8 and Other Product Types
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.8.3 and Other Product Types: Geographic Segmentation Analysis
Chapter 5: Opioids Market Application
5.1 Opioids Market Snapshot and Growth Engine
5.2 Opioids Market Overview
5.3 Strong Agonist and Mild to Moderate Agonist
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Strong Agonist and Mild to Moderate Agonist: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Opioids Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MALLINCKRODT PHARMACEUTICALS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 AMNEAL PHARMACEUTICALS INC.
6.4 HIKMA PHARMACEUTICALS PLC
6.5 PURDUE PHARMACEUTICALS L.P.
6.6 TEVA PHARMACEUTICALS INC.
Chapter 7: Global Opioids Market By Region
7.1 Overview
7.2. North America Opioids Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Codeine
7.2.2.2 Fentanyl
7.2.2.3 Morphine
7.2.2.4 Meperidine
7.2.2.5 Methadone
7.2.2.6 and Other Product Types
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Strong Agonist and Mild to Moderate Agonist
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Opioids Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Codeine
7.3.2.2 Fentanyl
7.3.2.3 Morphine
7.3.2.4 Meperidine
7.3.2.5 Methadone
7.3.2.6 and Other Product Types
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Strong Agonist and Mild to Moderate Agonist
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Opioids Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Codeine
7.4.2.2 Fentanyl
7.4.2.3 Morphine
7.4.2.4 Meperidine
7.4.2.5 Methadone
7.4.2.6 and Other Product Types
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Strong Agonist and Mild to Moderate Agonist
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Opioids Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Codeine
7.5.2.2 Fentanyl
7.5.2.3 Morphine
7.5.2.4 Meperidine
7.5.2.5 Methadone
7.5.2.6 and Other Product Types
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Strong Agonist and Mild to Moderate Agonist
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Opioids Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Codeine
7.6.2.2 Fentanyl
7.6.2.3 Morphine
7.6.2.4 Meperidine
7.6.2.5 Methadone
7.6.2.6 and Other Product Types
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Strong Agonist and Mild to Moderate Agonist
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Opioids Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Codeine
7.7.2.2 Fentanyl
7.7.2.3 Morphine
7.7.2.4 Meperidine
7.7.2.5 Methadone
7.7.2.6 and Other Product Types
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Strong Agonist and Mild to Moderate Agonist
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Opioids Scope:
|
Report Data
|
Opioids Market
|
|
Opioids Market Size in 2025
|
USD XX million
|
|
Opioids CAGR 2025 - 2032
|
XX%
|
|
Opioids Base Year
|
2024
|
|
Opioids Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, Purdue Pharmaceuticals L.P., Teva Pharmaceuticals Inc..
|
|
Key Segments
|
By Type
Codeine
Fentanyl
Morphine
Meperidine
Methadone
and Other Product Types
By Applications
Strong Agonist and Mild to Moderate Agonist
|
